- Home
- VERA vs DMLP Comparison
VERA vs DMLP Comparison
Compare VERA & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- DMLP
- Stock Information
- Founded
- VERA 2016
- DMLP 2003
- Country
- VERA United States
- DMLP United States
- Employees
- VERA N/A
- DMLP N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- DMLP Oil & Gas Production
- Sector
- VERA Health Care
- DMLP Energy
- Exchange
- VERA Nasdaq
- DMLP Nasdaq
- Market Cap
- VERA 1.4B
- DMLP 1.3B
- IPO Year
- VERA 2021
- DMLP N/A
- Fundamental
- Price
- VERA $21.27
- DMLP $25.05
- Analyst Decision
- VERA Buy
- DMLP
- Analyst Count
- VERA 8
- DMLP 0
- Target Price
- VERA $64.29
- DMLP N/A
- AVG Volume (30 Days)
- VERA 1.2M
- DMLP 129.2K
- Earning Date
- VERA 08-05-2025
- DMLP 08-07-2025
- Dividend Yield
- VERA N/A
- DMLP 12.85%
- EPS Growth
- VERA N/A
- DMLP N/A
- EPS
- VERA N/A
- DMLP 1.71
- Revenue
- VERA N/A
- DMLP $161,859,000.00
- Revenue This Year
- VERA N/A
- DMLP N/A
- Revenue Next Year
- VERA N/A
- DMLP N/A
- P/E Ratio
- VERA N/A
- DMLP $14.50
- Revenue Growth
- VERA N/A
- DMLP 4.04
- 52 Week Low
- VERA $18.53
- DMLP $24.12
- 52 Week High
- VERA $51.61
- DMLP $34.88
- Technical
- Relative Strength Index (RSI)
- VERA 48.60
- DMLP 27.42
- Support Level
- VERA $19.07
- DMLP $24.12
- Resistance Level
- VERA $22.74
- DMLP $26.84
- Average True Range (ATR)
- VERA 0.97
- DMLP 0.62
- MACD
- VERA 0.13
- DMLP -0.25
- Stochastic Oscillator
- VERA 59.99
- DMLP 23.97
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.